JUVENILE IDIOPATHIC ARTHRITIS (JIA)

This study tests whether the Butantan-Dengue vaccine is safe and works well in people aged 12–59 with autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are stable on low or no immune-suppressing drugs. Participants receive one vaccine dose and are monitored f…

This study is testing the long-term safety and effectiveness of the drug filgotinib in children and adolescents aged 8 to 17 with juvenile idiopathic arthritis. Participants must have already completed a previous filgotinib study and shown improvement. The goal is to see if the d…

This study tests whether doing core exercises through video games (exergaming) works as well as standard core exercises for children aged 8-13 with juvenile idiopathic arthritis. Both groups will exercise twice a week for 12 weeks. The goal is to see which approach better improve…

This study looks at 600 teens and young adults (ages 14-26) with conditions like juvenile arthritis, fibromyalgia, or past surgeries to understand why some develop long-lasting pain while others don't. Researchers will examine pain sensitivity, immune markers, and social factors …

This study looks at how parents' catastrophic thinking about their child's pain influences treatment in children with juvenile idiopathic arthritis (JIA). Researchers will survey 50 children aged 7-18 and their parents to measure pain-related thoughts, feelings, and overall well-…

This study is collecting blood and joint fluid samples from 300 children and young adults with juvenile idiopathic arthritis (JIA) to see if certain markers can predict how severe the disease will become. Researchers will track participants' symptoms, treatments, and joint damage…